CCB Form 144: Insider Notice to Sell 1,708 Shares ($186K)
Form 144 filed for ticker CCB discloses a proposed sale of 1,708 shares of common stock through Stifel Nicolaus & Company, with an aggregate market value of $186,350.
Rhea-AI Filing Summary
Form 144 filed for ticker CCB discloses a proposed sale of 1,708 shares of common stock through Stifel Nicolaus & Company, with an aggregate market value of $186,350. The shares represent a small fraction of the reported 15,109,090 shares outstanding. The securities were acquired as restricted stock units on 05/28/2025 and paid in cash on the same date. The approximate date of sale is listed as 09/15/2025. The filing does not identify the specific issuer name or the individual for whose account the sale is to be made; that information is absent from the provided form content.
Positive
- Clear transaction details including broker, acquisition date, RSU nature, and planned sale date are disclosed
- Relatively small size (1,708 shares) representing approximately 0.011% of reported shares outstanding, implying limited market impact
Negative
- Issuer name and selling person's identity are not provided in the supplied content, reducing transparency
- Sale involves recently vested RSUs, which could be viewed as insider liquidity rather than long-term commitment
Insights
TL;DR: Small insider sale of recently vested RSUs; immaterial to capital structure but worth noting for insider activity tracking.
The filing documents an intent to sell 1,708 shares valued at $186,350 via a broker on 09/15/2025. The shares were granted and settled as restricted stock units on 05/28/2025. Relative to the reported 15,109,090 shares outstanding, the amount represents roughly 0.011% of outstanding shares, which is immaterial from a dilution or market-cap perspective. The lack of a named issuer and the unnamed selling person in the provided content limits attribution and context for evaluating motives or timing.
TL;DR: Proper Rule 144 disclosure filed, but missing issuer/person details reduce transparency for investors.
The form shows compliance with Rule 144 mechanics: acquisition date, nature (RSUs), broker details, and intended sale date are provided. However, the provided extract omits the issuer's name and the identity/relationship of the seller, which are material for governance oversight and insider-transaction monitoring. That omission prevents a full assessment of potential conflicts or insider signaling.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the CCB Form 144 disclose about the proposed sale?
When were the securities acquired according to the filing?
Does the filing name the issuer or the selling person?
Which broker is handling the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.